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ABSTRACT
Purpose of the study: Macular pigment (MP), comprising the dietary carotenoids lutein, zeaxanthin and 
meso-zeaxanthin, is believed to benefit eye health and vision. Numerous clinical and research devices and 
techniques are currently available to facilitate MP optical density (MPOD) measurement. One of those 
techniques, dual-wavelength fundus autofluorescence (AF) is being increasingly used for measurement of 
MP in the eye. There is substantial methodological variation across the published studies that have 
employed this technique, including in relation to the use of mydriasis, the possible influence of which 
does not appear to have been addressed in the literature. This prospective cross-sectional study was 
designed to investigate the effect of mydriasis on MP measurement quality and MPOD values obtained 
with dual-wavelength AF using the Heidelberg Spectralis HRA+OCT device.
Materials and Methods: Twenty-one healthy participants were recruited to the study. The mean age of 
participants was 44.8 years (± 14.63). Pupil size and MPOD were measured in one eye for each participant, 
initially under natural pupil conditions and subsequently 30 minutes following instillation of one drop of 
0.5% tropicamide.
Results: Despite providing MPOD measurements for the majority of undilated eyes (85.7% of eyes herein), 
pupillary dilation resulted in statistically significant changes in MPOD (p < .001 for central eccentricities). 
Our results indicate that the changes in MPOD were not uniform across the spatial profile. Marked 
improvements were also observed in image quality post-dilation (p < .002 for central eccentricities).
Conclusions: This study clearly demonstrates that dual-wavelength AF measurements of MPOD in the 
same eye vary as a function of pupillary dilation status, with MPOD under-estimated across the entire 
spatial profile of MP for natural relative to dilated pupillary conditions. Mydriasis should, therefore, be 
used routinely for MPOD measurements using dual wavelength AF, pupil size should be reported and 
image quality optimized in order to ensure accurate MPOD quantification.
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Macular pigment (MP) is composed of the three dietary car-
otenoids: lutein (L), zeaxanthin (Z), and meso-zeaxanthin 
(MZ) which accumulate selectively in the retina, giving the 
macula lutea its characteristic yellow appearance. MP’s consti-
tuent carotenoids possess short-wavelength light-filtering, 
antioxidant, anti-inflammatory, and neuro-protective proper-
ties, which are believed to benefit eye health and vision.1,2 
L and Z are also found in several specific regions in the brain 
including the frontal, occipital, and temporal cortices, hippo-
campus, and cerebellum.3–6 Studies have demonstrated that 
MP can be augmented by supplementation or by incorporating 
more carotenoid-rich food into the diet.7,8 MP and its consti-
tuent carotenoids have been studied extensively for their role in 
eye health and in the prevention of retinal disease such as age- 
related macular degeneration and, more recently, conditions 
such as diabetes and glaucoma.9–11 There is also a limited body 
of research exploring the role of MP for cognitive health.12–14 
To study the role of MP for ocular and cognitive health, a valid 
measure of MP in the eye is required.
Heterochromatic flicker photometry (HFP) is accepted as 
the gold standard for measurement of MPOD.15,16 However, 
HFP requires good vision and is reliant on participants to 
follow detailed instructions, sustain concentration, and fixation 
over an extended period. MPOD can, therefore, prove difficult 
to measure using the HFP technique, particularly in older 
participants with ophthalmic disease such as glaucoma.9,17 It 
also takes considerable time to obtain MP data at sufficient 
retinal eccentricities to build up a spatial profile of MPOD 
using HFP.
Dual-wavelength fundus autofluorescence (AF) is less 
widely used, but provides a non-psychophysical method of 
measuring MPOD based on detection of the fluorescence 
derived from lipofuscin.18 The technique requires minimal 
participation by the subject, who is required only to fixate on 
an internal target within the system for 30 seconds. Dual- 
wavelength AF has been shown to achieve reliable and repro-
ducible measures of MPOD.19,20 This technique provides an 
additional benefit as it measures the entire spatial profile (see 
Figure 1) and volume of MP (compared to the isolated single 
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points measured by HFP). Although the device required for 
dual-wavelength fundus AF measurement is significantly more 
expensive than HFP, this technique provides more information 
regarding the complete spatial profile of MPOD at any single 
measurement, and enhanced capacity to detect any change 
across this profile in response to temporal variation in dietary 
intake, supplement use, or disease status.
Dual-wavelength AF measurements of MPOD in healthy 
participants have been shown to demonstrate good agreement 
with measurements using HFP,20 customized HFP,19 and 
a dual-wavelength reflectance technique.20 Additionally, 
MPOD measured with this method appears to correlate well 
with serum L and Z, and with skin carotenoid levels.21 It has 
been previously reported, however, that cataract may result in 
underestimated MPOD when using AF,22,23 so it would seem 
prudent to account for cataract status in dual-wavelength AF 
measurements of MPOD. Dual-wavelength AF has also been 
demonstrated to be capable of detecting change in MPOD 
following supplementation.24–26
The possible influence of pupil size on MPOD measurement 
using dual-wavelength AF does not appear to have been 
addressed in the literature. In most cases, it is possible to 
measure MPOD under natural un-dilated pupil conditions, 
even though the measurement requires exposure to an intense 
light source. Although pupillary dilation is generally accepted 
as a methodological requirement for MPOD measurement 
using dual-wavelength AF, a review of the available literature 
reveals numerous published studies that do not report using 
mydriatic eye drops to dilate the pupil before MPOD measure-
ment with this technique.24,27–31 Moreover, even in studies that 
report dilating for dual-wavelength fundus AF MPOD mea-
surement, specific detail such as the actual pupil size following 
dilation is not typically provided.32–34 Importantly, only three 
of the (circa 100) studies that we reviewed, reported using 
a measure of MPOD image quality, a feature which is not 
provided inherently by the device.19,22,35
Methods
This prospective cross-sectional study was designed to investi-
gate the effect of mydriasis on MP measurement quality and 
MPOD values obtained with dual-wavelength AF using the 
Heidelberg Spectralis HRA+OCT MultiColor (Heidelberg 
Engineering GmbH, Germany).
Twenty-one healthy subjects without retinal pathology or 
cataract were recruited into the study. The mean age of parti-
cipants was 44.8 years (± 14.63), with a range from 27 to 
70 years.
A comprehensive ocular examination was conducted to 
determine eye health, including a review of ocular and medical 
history, distance monocular visual acuity (VA) using ETDRS 
chart with participant’s spectacles, slit lamp, and Volk lens 
examination, intraocular pressure measurement with the 
Icare ic100 tonometer, fundus imaging, and glaucoma module 
assessment using the Spectralis HRA+OCT device. The eye 
with better VA was selected as the study eye. All subjects had 
good vision, with a mean LogMAR visual acuity in the study 
eye of −0.12 (± 0.1) (Snellen equivalent 6/5 + 1).
The study was explained to each participant before obtain-
ing written informed consent. The study was approved by the 
Research Ethics and Integrity Committee at Technological 
University Dublin (TU Dublin) and conformed to the tenets 
of the Declaration of Helsinki.
Order of procedures
First, minimum pupil size was measured using the Aladdin 
optical biometer (Topcon, Tokyo, Japan). Immediately after 
this, the first MPOD measurement was obtained using the 
Spectralis device. The study eye was then dilated with one 
drop of 0.5% tropicamide (Bausch + Lomb, Surrey, United 
Kingdom). After 30 minutes, a second set of pupillometry 
and MPOD measurements were captured. All measurements 
were obtained by the same examiner (EL).
Minimum pupil size measurement
The Aladdin biometer uses white light-emitting diodes (LEDs) 
to produce photopic light conditions and to constrict the pupil. 
Minimum pupil diameter was automatically measured using 
dynamic pupillometry. Pupil size was measured in a darkened 
room (lux levels at the eye when using the Aladdin device: 
<0.01 lux). Pupil size was recorded continuously for 20 seconds 
following exposure to a 0.4 mW bright LED flash. A graph of 
pupil size over time was plotted and minimum pupil size was 
recorded automatically as the lowest recorded size (typically 
reached within one to two secondspost flash).
MPOD measurement
MPOD was measured using a dual-wavelength AF method, as 
described previously,36,37 using the Heidelberg Spectralis. This 
device uses a confocal scanning laser ophthalmoscope (cSLO) 
and two excitation wavelengths (486 nm [blue light which is 
well absorbed by MP] and 516 nm [green light, absorption of 
Figure 1. Example of MP Spatial profile output obtained with dual-wavelength 
autofluorescence using the Heidelberg Spectralis® HRA + OCT Multicolor 
(Heidelberg Engineering GmbH, Heidelberg, Germany) for undilated (left) and 
dilated (right) conditions in the same eye. Note: retinal eccentricity is provided on 
the X-axis and MPOD on the Y-axis. MPOD is indicated by the central dark thin line 
located in the middle of the green zone. The width of the green zone provides a 
visual indication of the standard deviation of the measures on MPOD at each 
eccentricity (no quantitative data are provided as to the size of the standard 
deviation). A wider green zone indicates greater standard deviation in the MPOD 
measurement, equating to a poorer quality measure. The blue bars above and 
below the green zone provide the minimum and maximum MPOD values mea-
sured at each eccentricity (again, no quantitative output is given as a measure of 
this minimum and maximum value, just the visual representation).
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which by MP is low]). The light intensity of the green and blue 
diode lasers in the Heidelberg Spectralis device is 0.44 mW.
AF images of the 30° central area of the retina were recorded 
for both wavelengths and foveal fluorescence was compared 
with a parafoveal reference point set at 6° retinal eccentricity. 
MP density maps were then computed by the Heidelberg Eye 
Explorer software (HEYEX, version 1.9.13.0) by analyzing the 
AF images obtained at both wavelengths. As absorption of MP 
at 486 nm is high, and at 516 nm is close to zero, and there is 
virtually no MP in the parafoveal region that is used as 
a reference, total MP and its spatial profile could be determined 
(Figure 1).
MPOD measurements were obtained in a darkened room 
(lux levels at the eye when using the Spectralis device: 1 lux). 
After ensuring the correct positioning of the participant’s head 
against the chin- and headrest, the AF mode was activated by 
switching the lever on the camera head to the vertical down 
position. The acquisition panel was then turned on, after which 
alignment, focus, and illumination were optimized in reflected 
infrared mode (IR). Then, IR mode was switched to blue AF + 
green AF (BAF+GAF) mode. Focus and image brightness were 
readjusted in the BAF+GAF mode. Subjects were advised that 
they could blink if necessary. After at least 15 seconds of retinal 
bleaching, sequences of images were captured (recorded as 
a 30 second movie), which were then processed using an 
averaging technique by the Spectralis device. MP plots with 
MPOD values for circles centered on the fovea were automa-
tically generated.
MPOD volume at 6° retinal eccentricity as well as MPOD at 
0.23, 0.51, 0.74, 0.98, 1.25, 1.48, 1.76, 1.99, 2.5, 3.01 degrees 
retinal eccentricity were obtained from the resulting MPOD 
plots. In addition, standard deviations (SDs) of MPOD at three 
eccentricities (0.23, 0.98, and 1.99) the green bars on Figure 1 
were read from the plots using an open-source graph reader 
(graphreader.com). SDs at the three retinal eccentricities were 
used as an indicator of image quality.
Statistical analysis was performed using the SPSS statistical 
software package, V.24.0 (IBM-SPSS, Chicago, Illinois, USA). 
Figures were produced using the Microsoft R Studio package 
for Windows (R Core Team, 2019).38
Results
Undilated AF images with acceptable quality for MP calcula-
tion could be obtained for 18 subjects. In three subjects 
(14.3%), two attempts at capturing dual-wavelength AF video 
were made, but resulted in images that could not be processed 
by the device software. Successful measurements of MPOD 
were obtained for all 21 participants post-dilation. A marked 
improvement in image quality features (including SD, mini-
mum and maximum values) was observed for every participant 
across the entire spatial profile of MP under dilated pupillary 
conditions (Figure 1).
Statistical analysis was performed on the 18 eyes of 18 
subjects with available pre- and post-mydriasis MPOD and 
pupillometry measurements.
MPOD, SD and minimum pupil size
A paired samples t-test was conducted to compare MPOD 
volume, individual MPOD measurements at four commonly 
reported central eccentricities, minimum pupil size, and SD 
values at three selected eccentricities pre- and post-mydriasis. 
Pre-dilation measures of minimum pupil size, MPOD at all 
eccentricities, MPOD volume, and all SDs were statistically 
significantly different from those obtained post-dilation even 
after Bonferroni correction for multiple testing (paired- 
samples t-test, p ≤ 0.002 for all). Of note, SD values were 
substantially higher pre-mydriasis in every participant, with 
the mean SD between 2.2 and 2.8 times higher at the measured 
eccentricities under natural pupil conditions. The detailed pre- 
and post-dilation pupil size, SD, and MPOD data at commonly 
reported eccentricities are presented in Table 1. All data apart 
from SDs were normally distributed. To account for the non- 
normal distribution of the SD data, Spearman’s correlation- 
ranked order was used.
Figure 2 shows the spatial profile of mean MPOD for undi-
lated (red) and dilated (green) pupils 30 minutes after instilla-
tion of tropicamide 0.5%. A repeated measures mixed ANOVA 
was conducted including the factors dilation status (undilated 
and dilated) and eccentricities (0.23°, 0.51°, 0.74°, 0.98°, 1.25°, 
1.48°, 1.76°, 1.99°, 2.5°, 3.01°). A statistically significant effect of 
dilation status (F (1,17) = 73.134, p < .001) and eccentricity (F 
(9,153) = 163.619, p < .001) and a statistically significant inter-
action of dilation status and eccentricity (F (9,153) = 9.282, 
p < .001) was detected. Figure 2 illustrates the systematically 
higher MPOD values obtained following pupil dilation across 
the entire spatial profile of MP. The mean change in MPOD is 
not uniform however, with the highest level of change observed 
centrally (~20% for the two most central eccentricities), while 
Table 1. Minimum pupil size, MPOD, and SD data before and after mydriasis.
Parameter Undilated (mean ± SD) Dilated (mean ± SD) t (17) P value
Minimum pupil size 3.22 ± 0.64 5.5 ± 0.88 −9.953 < 0.001
MPOD, mean
0.23° 0.38 ± 0.08 0.46 ± 0.08 −5.2 < 0.001
0.51° 0.31 ± 0.09 0.37 ± 0.1 −5.477 < 0.001
0.74° 0.32 ± 0.09 0.37 ± 0.09 −4.593 < 0.001
0.98° 0.28 ± 0.08 0.31 ± 0.08 −5.394 < 0.001
Volume, at 6° 3928.29 ± 2035.65 4884.43 ± 2133.28 −11.529 < 0.001
MPOD plot SD 0.23† 0.17 ± 0.1 0.06 ± 0.02 4.811 < 0.001
MPOD plot SD 0.98† 0.13 ± 0.07 0.06 ± 0.03 3.908 < 0.001
MPOD plot SD 1.99† 0.11 ± 0.07 0.04 ± 0.02 4.682 < 0.001
P-value obtained using the paired samples t-test and a Wilcox Rank Sum test for the SD data. Minimum pupil size under bright illumination (light 
intensity 0.4 mW). †SD – standard deviation as derived from the green bars on MPOD plots.
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the difference is relatively consistently lower at more peripheral 
eccentricities. The statistically significant interaction between 
dilation and eccentricity is illustrated in the plot of the sub-
traction of dilated and undilated MPOD at each retinal eccen-
tricity (insert of Figure 2).
Image quality and its relationship to pupil size
Figure 3 illustrates a marked reduction and compression of 
MPOD SD values, reflecting the improvement in image quality 
of the MPOD measurement following dilation for three indi-
cative retinal eccentricities (0.23°, 0.98° and 1.99°).
To investigate the effect of dilation and eccentricity on the SD 
of MPOD, a repeated measures mixed ANOVA was conducted 
with the factors being dilation status (undilated, dilated) and 
eccentricities (0.23, 0.98, 1.99). A statistically significant effect of 
dilation status (F (1,17) = 18.114, p = .001) and eccentricity (F 
(2,34) = 15.859, p < .001) and an interaction of dilation status 
and eccentricity was observed (F = 8.395, p = .009).
A linear regression was calculated to investigate the SD mea-
sures obtained from the MP graph at 0.23° retinal eccentricity as 
a function of pupil size and to determine a cut-off value for 
acceptable MPOD measurement quality. The simple linear regres-
sion showed a significant relationship between SD measures 
obtained from the MP graph at 0.23° retinal eccentricity as 
a function of minimum pupil size (F (1,34) = 15.64, p < .001). 
The slope coefficient for pupil size was −0.03711 (t (34) = −3.995, 
p < .001) with the intercept of 0.274813 (t (34) = 6.412, p < .001). 
The R2 value was 0.3151 so 31.5% of the variation in the SD of 
MPOD was explained by the model containing pupil size. This 
model gives the formula of (SD of MPOD) = −0.037 (Pupil size) + 
0.274813.
An unsupervised k-means cluster analysis was conducted to 
categorize two clusters by minimum pupil size and SD mea-
sures obtained from the MP graph at 0.23° retinal eccentricity. 
A scatter plot of each subjects SD of MPOD at 0.23° as 
a function of pupil size and dilation status was produced with 
subject data assigned to a classification cluster. The analysis 
resulted in the classification of two equal groups of 18, the first 
cluster contained 17 of the 18 participants post-dilation with 1 
participant misclassified. In the second cluster, 17 of the 18 
participants were classified as undilated with 1 participant 
misclassified (Figure 4). The unsupervised analysis resulted in 
a 94.4% accuracy of classification. The pupil size of 4.35 mm 
indicated by the vertical-dashed blue line which corresponds to 
the midpoint between cluster 1 and cluster 2 (Figure 4). Using 
the linear regression equation derived above, a 4.35 mm pupil 
size yields a predicted SD value of 0.11 which could be used as 
a cut-off value for acceptable MPOD measurement quality.
Discussion
This study provides comprehensive evidence that pupil size is 
an important consideration in the measurement of MP using 
Figure 2. Mean and standard error of the spatial profile of MPOD across the 
central 3°, for undilated (red) and dilated (green) 30 minutes after instillation of 
tropicamide 0.5%. Insert – Subtraction of undilated from dilated MPOD at each 
retinal eccentricity.
Figure 3. Boxplot and individual subject data of standard deviation of MPOD 
measurement at 0.23°, 0.98° and 1.99° for undilated (red) and dilated (green) 
measurements.
Figure 4. Scatter plot showing relationship between minimum pupil size and SD 
of the MPOD at 0.23° retinal eccentricity. Green (dilated) and red (undilated) 
colors indicate pupil dilation status for each subject; blue line indicates the 
bisection line; the triangle and circle symbols indicated which k-means classifica-
tion cluster the subject data was assigned to.
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the Spectralis dual-wavelength fundus AF device. Despite pro-
viding MPOD measurements for the majority of undilated eyes 
(85.7% of eyes herein), two critical observations can be made in 
relation to the impact of mydriasis. First, larger pupils facilitate 
better quality MPOD measures, evidenced by the tighter SDs 
(note the shorter green bars visible in Figure 1) and narrower 
range (note the variation in blue bars in Figure 1) observed 
post-dilation. This improvement in image quality and capacity 
to measure MPOD is not surprising given that the intensity of 
the stimuli used would cause a strong miotic response under 
natural pupillary conditions. Second, and perhaps more 
importantly, MPOD measurements in the same eye vary as 
a function of pupillary dilation status, with MPOD invariably 
under-estimated across the entire spatial profile of MP for 
natural relative to dilated pupillary conditions.
Dual-wavelength fundus AF is being increasingly used for 
the determination of ocular MPOD levels as it offers distinct 
benefits over other techniques. The time required to capture 
MPOD measurements is substantially reduced compared to 
psychophysical techniques so participant fatigue is no longer 
a measurement consideration.39 Additionally, it provides much 
more detailed information on the spatial profile of MP and the 
graphical output is clinically useful,40 particularly in relation to 
the evaluation of MPOD change over time. Of note, although 
Spectralis gathers clinically useful information on the entire 
special profile of MP, the density of carotenoid deposits 
decreases rapidly at extrafoveal eccentricities, which leads to 
increased variability in peripheral MP measures. Analysis of 
individual data points should, therefore, prioritize central MP 
measures including for the assessment of quality indices.
The measurements have proven to be relatively robust in 
terms of reproducibility over time in the absence of cataract.20 
Good within-session repeatability has also been shown, 
although a higher coefficient of repeatability for MPOD mea-
sures inside 0.1° of retinal eccentricity has prompted the sug-
gestion to capture multiple MPOD measures to ensure robust 
values.41 Dual-wavelength AF devices used to measure MPOD 
are not generally commercially available to clinicians, so there 
are no practical guidelines available regarding a standardized 
method of measurement. Additionally, although the 
Heidelberg Spectralis provides a detailed graphical representa-
tion of the MPOD measurement, it does not provide any 
quantitative index of image quality or measurement accept-
ability. Although the differences in Figures 1 and 3 are marked, 
there is nothing in the measurement output to indicate at what 
point an acceptable level of quality has been achieved. Given 
the variation in MPOD values obtained under the two condi-
tions, analysis of the graphical outputs to determine measure-
ment acceptability would seem prudent.
In a clinical environment, it would be highly beneficial to 
avoid the necessity for dilation. Time and cost savings would 
benefit practitioners, patients would save time too and would 
avoid the short-term quality of life impact of dilation on visual 
comfort and performance. It could be argued that these bene-
fits might outweigh a slight underestimation of MPOD. The 
level of underestimation in natural pupillary conditions was 
not consistent, however, either between participants or across 
the spatial profile of MP within participants. The difference in 
MPOD volume following dilation, for example, ranged 
between 263.61 and 1523.54 units of optical density volume. 
Moreover, the profile of MP overall was also different in pre- 
and post-mydriasis measurements. As illustrated in Figure 2, 
the profile of MP for undilated measurements appears flattened 
centrally relative to the periphery, not showing the full extent 
of the peak MPOD as observed in dilated conditions. The 
statistically significant interaction between dilation and eccen-
tricity as illustrated on the insert in Figure 2 would suggest that 
any correction factor would need to incorporate retinal eccen-
tricity as a means to adjust MPOD based on undilated 
measurements.
From a research perspective, our analysis of the methodo-
logical approach adopted in the published literature involving 
dual-wavelength AF for MPOD measurement reveals substan-
tial variation between studies and, in many cases, insufficient 
detail to determine the validity of the MPOD findings. The lack 
of standardized approach to the measurement creates difficulty 
in relation to the interpretation of the relative findings reported 
across the various studies and may even invalidate the out-
comes of some.
This is not the first study to demonstrate differences in 
MPOD measurements associated with the quality of measure-
ment taken. The presence of cataract has also been shown to 
cause an underestimation of MPOD when measured using 
dual-wavelength AF by comparing MPOD levels pre- and post- 
cataract surgery.22 It appears that the magnitude of difference 
in MP values was much higher (approximately 5 times higher) 
between then pre- and post-cataract measurements (0.26 opti-
cal density units at 0.51° retinal eccentricity and 4.452 optical 
density units for volume at 8.98°) when compared to the pre- 
and post-mydriasis measurements in the current study (0.059 
optical density units at 0.51° retinal eccentricity and 956.14 
optical density units for volume at 8.98°). Also baseline mea-
surements could not be obtained for a higher percentage of 
participants in the cataract study (33% compared to 14.3% in 
our study). This suggests that the effect of cataract on measure-
ment is a lot more pronounced than that of the pupil size. 
Statistically significant variation of MP, however, was observed 
through all of the central eccentricities analyzed. The image 
quality index (IQI) calculated in the cataract study is very 
specific to cataract and therefore not useful in its current 
format for more general use.22
The protocol adopted herein, to measure MPOD 30 minutes 
after instillation of 0.5% tropicamide, was sufficient to allow 
a high degree of classification accuracy in our cluster analysis 
without any other assumptions. Dilated pupils tended to be 
larger than 4 mm under bright light stimulation (in 96% of 
cases, with the other one case just below 4 mm), which deliv-
ered statistically significantly better image quality according to 
the computed SDs (mean SD values for dilated pupils ranged 
from 0.04 to 0.1). The 4 mm finding is entirely consistent with 
the optical set up of the dual-wavelength AF device. The 
incident blue and green laser beams intercept the pupil plane 
in a 1–2 mm diameter spot. The emitted AF is captured by the 
entrance pupil (detection system), which has a diameter of 
4 mm. Thus, if the pupil is less than 4 mm, less light will be 
available for analysis, and noise will increase. The blue light 
image in the fovea (lowest fundus AF) may reach levels of non- 
linear behavior with increased noise levels. The green light 
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image and more peripheral sites at both wavelengths will be 
less affected because the AF is larger, hence leading to the 
observed underestimation of MPOD and variation in degree 
of underestimation across its spatial profile. On the basis of 
these outcomes, we would suggest that future studies consider 
implementation of a standardized methodological approach to 
MPOD measurement using dual-wavelength AF. This 
approach should include sufficient mydriasis to allow 
a minimum pupil size greater than 4 mm under intense bright 
light stimulation. The methodological approach should also be 
more comprehensively described. Additionally, the reporting 
of MPOD should include a quality metric such as the SD values 
reported herein, and consideration given to the rejection of 
MPOD values that do not meet SD criteria. In our study, for 
minimum pupil size under bright illumination conditions of 
over 4 mm, SD values at 0.23° eccentricity ranged from 0.04 to 
0.1. Using the linear regression equation, the 0.13 predicted SD 
value at 0.23° eccentricity for a pupil size of 4 mm may provide 
a reasonable cut-off value for acceptable MPOD measurement 
quality (SD values were typically lower more peripherally).
Limitations
One of the limitations of this study is that pupil size and 
MPOD are measured using two different devices and there 
was a short time gap between conducting pupillometry and 
measuring MPOD. The light intensity in the Spectralis device is 
higher than that used in the Aladdin device, so that the mini-
mum pupil size during MPOD measurement could be slightly 
smaller than that recorded using Aladdin. Another limitation is 
the relatively small sample size, as the undilated measurement 
could be obtained only for 18 subjects. However, the sample 
size was sufficient to show highly statistically significant differ-
ences between pre- and post-dilation MPOD and SD values 
across the spatial profile of MP, and allowed the estimation of 
the suggested cut-off point for pupil size and quality of mea-
surement. One final possible limitation relates to the use of 
0.5% tropicamide as the mydriatic agent. Most studies that 
have reported the type of mydriatic agent used have employed 
tropicamide plus phenylephrine, or if used alone, a more 
potent 1% tropicamide concentration. Although it might be 
perceived as a limitation, the use of the lower 0.5% concentra-
tion herein was deliberate for two reasons. First, the lower 
concentration offers benefits in terms of the lesser and shorter 
duration quality of life impact on study participants and 
patients in clinical practice. Second, and more importantly, it 
was implemented as a means to determine whether any effects 
observed might relate to the degree of mydriasis induced. The 
use of the 0.5% concentration resulted in a broad range of post- 
dilation pupil size from just under 4 mm to over 7 mm. It was 
felt that a higher concentration may cause a greater average 
increase in pupil size but narrower overall range. Figure 4 
demonstrates very clearly the absence of any relationship 
between the measurement SD and pupil size post-dilation 
despite the more than 3 mm range of pupil size. As such, this 
study demonstrates that measurement quality is essentially 
independent of the type of mydriatic used once sufficient 
mydriasis is induced to yield a minimum photopic pupil dia-
meter of no less than 4.35 mm.
Of note, pupil size in the current study was measured using 
an automated pupillometer. However, it has been shown that 
there is no significant disagreement between manual and auto-
mated pupillometer measurements, so the suggestions for 
pupil size presented in the current study can be applicable to 
both automated and manual pupil size measurements.42
Conclusions
In conclusion, this study confirms that pupillary dilation is 
required for accurate measurement of MPOD when using the 
dual-wavelength AF technique, and reinforces that the mea-
surement protocol should include confirmation that pupil size 
exceeds the entrance pupil size of the device (in this case 4 mm) 
under intense bright light stimulation. Although the 
Heidelberg Spectralis device does not provide a quantitative 
indicator for the MP measurement quality, SD values at each 
retinal eccentricity indicative of image quality can be extracted 
from the graphical output. Our data indicate that a cut-off SD 
value at 0.23° retinal eccentricity of 0.11 may provide a simple 
clinical guide to ensure optimal image quality. Numerous 
published studies do not report using mydriatic eye drops to 
dilate the pupil before MPOD measurement, or omit specific 
detail such as the actual pupil size following dilation with this 
technique.24,27-31 Future publications should, therefore, pro-
vide more specific detail on the treatment of pupils and the 
resultant quality metrics obtained in the respective studies to 
allow more complete and accurate assessment of the reported 
findings.
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